Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 18/20 | 0.43 |
| ▸ | JAK2 | O60674 | 13/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.35 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.35 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.35 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.35 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.35 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.35 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20184377 | 0.88 | JAK3 (0.56) | JAK3JAK2HSP90AB1 | |
| SCHEMBL20184679 | 0.87 | JAK3 (0.56) | JAK3JAK2PRKAB2PRKAG1PRKAA2 | |
| SCHEMBL20184515 | 0.86 | JAK3 (0.56) | JAK3JAK2 | |
| SCHEMBL20184555 | 0.84 | HSP90AB1 (0.43) | JAK3JAK2HSP90AB1 | |
| SCHEMBL20184670 | 0.84 | HSP90AB1 (0.42) | JAK3JAK2HSP90AB1 | |
| SCHEMBL20184536 | 0.84 | JAK3 (0.47) | JAK3JAK2 | |
| SCHEMBL20184581 | 0.83 | JAK3 (0.43) | JAK3JAK2 | |
| SCHEMBL20184599 | 0.83 | JAK3 (0.53) | JAK3JAK2HSP90AB1 | |
| SCHEMBL20184700 | 0.82 | JAK2 (0.40) | JAK3JAK2PRKAB2PRKAG1PRKAA2 | |
| SCHEMBL20184554 | 0.82 | JAK3 (0.39) | JAK3JAK2HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788000-B1 | PYRROLOPYRIMIDINES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2018-05-30 | — | — | EP | claimed |